2-Deoxystreptamine conjugates by truncation-derivatization of neomycin

Pharmaceuticals

Volumn 3, Issue 3, 2010, Pages 679-701

  Aslam, M Waqar ^a   Tabares, Leandro C ^b   Andreoni, Alessio ^b   Canters, Gerard W ^b   Rutjes, Floris P J T ^a   van Delft, Floris L ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Aminoglycosides; Aminopyridine; Aminoquinoline; Biosensor; Fluorescence; Hemocyanin; Morpholine

Indexed keywords

1 (AZIDOMETHYL) 2 METHOXYBENZENE; 1 (AZIDOMETHYL) 4 METHOXYBENZENE; 1 AZIDO 4 BROMOBENZENE; 1 AZIDO 4 METHOXYBENZENE; 1 BROMO 4 (AZIDOMETHYL)BROMOBENZENE; 2 (2 AMINOETHYLAMINO) 4 METHYLPYRIDINE; 2 (2 AMINOETHYLAMINO) 4 METHYLQUINOLINE; 2 (2 AMINOETHYLAMINO) 5 METHYLPYRIDINE; 2 DEOXYSTREPTAMINE; 5 O (BETA DEXTRO RIBOFURANOSYL) 2 DEOXYSTREPTAMINE; 5 O (N PROPYN 1 YL MORPHOLINO) 2 DEOXYSTREPTAMINE; 5 O [N PROPYN 1 YL 2 (METHYLAMINO N ETHYLAMINO N 4 METHYLPYRIDIN 2 YL)MORPHOLINO] 2 DEOXYSTREPTAMINE; 5 O [N PROPYN 1 YL 2 (METHYLAMINO N ETHYLAMINO N 5 METHYLPYRIDIN 2 YL)MORPHOLINO] 2 DEOXYSTREPTAMINE; 5 O [N PROPYN 1 YL 2 (METHYLAMINO N ETHYLAMINO N 5 METHYLQUINOLIN 2 YL)MORPHOLINO] 2 DEOXYSTREPTAMINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPYRIDINE; AMINOQUINOLINE DERIVATIVE; ETHYLENEDIAMINE DERIVATIVE; HEMOCYANIN; KANAMYCIN; NEOMYCIN; REAGENT; UNCLASSIFIED DRUG;

AMINATION; ANTIBACTERIAL ACTIVITY; ARTICLE; BINDING AFFINITY; BIOSENSOR; DERIVATIZATION; DIMERIZATION; DRUG DEGRADATION; DRUG SYNTHESIS; ESCHERICHIA COLI; FLUORESCENCE RESONANCE ENERGY TRANSFER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; OXIDATION REDUCTION REACTION; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 77950452367     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3030679     Document Type: Article

References (72)

1. Zembower, T.R.; Noskin, G.A.; Postelnick, M.J.; Nguyen, C.; Peterson, L.R. The Utility of Aminoglycosides in an Era of Emerging During of Resistance. Int. J. Antimicrob. Agents 1998, 10, 95-105.
2. Recht, M.I.; Douthwaite, S.; Puglisi, J.D. Basis for Prokaryotic Specificity of Action of Aminoglycoside Antibiotics. EMBO J. 1999, 18, 3133-3138.
3. Beaucaire, G. The role of aminoglycosides in Modern Therapy. J. Chemother. 1995, 7, 111-123.
4. Zhao, F.; Zhao, Q.; Blount, K.F.; Han, Q.; Tor, Y.; Hermann, T. Molecular Recognition of RNA by Neomycin and a Restricted Neomycin Derivative. Angew. Chem. Int. Ed. 2005, 44, 5329-5334.
5. Magnet, S.; Blanchard, J.S. Molecular Insights into Aminoglycoside Action and Resistance. Chem. Rev. 2005, 105, 477-497.
6. Zembower, T.R.; Noskin, G.A.; Postelnick, M.J.; Nguyen, C.; Peterson, L.R. The Utility of Aminoglycosides in an Era of Emerging During of Resistance. Int. J. Antimicrob. Agents 1998, 10, 95-105.
7. Nagai, J.; Takano, M. Molecular Aspects of Renal Handling of Aminoglycoside and Strategies for Preventing the Nephrotoxicity. Drug Metab. Pharmacokinet. 2004, 19, 159-170.
8. Hayashi, S.F.; Norcia, L.J.; Seibel, S.B.; Silvia, A.M. Structure-activity Relationships of Hygromycin A and its Analogs: Protein Synthesis Inhibition Activity in a Cell-Free System. J. Antibiot. 1997, 50, 514-521.
9. Hotta, K.; Zhu, C.B.; Ogata, T.; Sunada, A.; Ishikawa, J.; Mizuno, S.; Kondo, S. Enzymatic 2'-N-Acetylation of Arbekacin and Antibiotic Activity of its Product. J. Antibiot. 1996, 49, 458-464.
10. Shaw, K.J.; Rather, P.N.; Hare, R.S.; Miller, G.H. Molecular Genetics of Aminoglycoside Resistance Genes and familial Relationships of the Aminoglycoside-Modifying Enzymes. Microbiol. Rev. 1993, 57, 138-163.
11. Rai, R.; Chen, H.N.; Czyryca, P.G.; Li, J.; Chang, C.W.T. Design and Synthesis of Pyrankacin: A Pyranmycin Class of Broad-Spectrum Aminoglycoside Antibiotic. Org. Lett. 2006, 8, 887-889.
12. Wang, J.; Li, J.; Chen, H.N.; Chang, H.; Tanifum, C.T.; Liu, H.H.; Czyryca, P.G.; Chang, C.W.T. Glycodiversification for the Optimization of the Kanamycin Class Aminoglycosides. J. Med. Chem. 2005, 48, 6271-6285.
13. Ding, Y.; Hofstadler, S.A.; Swayze, E.E.; Risen, L.; Griffey, R.H. Design and Synthesis of Paromomycin-Related Heterocycle-Substituted Aminoglycoside Mimetics Based on a Mass Spectrometry RNA-Binding Assay. Angew. Chem. Int. Ed. 2003, 42, 3409-3412.
14. Kudyba, I.; Fernandez, D.P.; Bottger, E.C.; Vasella, A. Synthesis of Paromomycin Derivatives Modified at C(5'') to Selectively Target Bacterial rRNA. Carbohydr. Res. 2007, 342, 499-519.
15. Francois, B.; Szychowski, J.; Adhikari, S.S.; Pachamuthu, K.; Swayze, E.E.; Griffey, R.H.; Migawa, M.T.; Westhof, E.; Hanessian, S. Antibacterial Aminoglycosides with a Modified Mode of Binding to the Ribosomal-RNA Decoding Site. Angew. Chem. Int. Ed. 2004, 43, 6735-6738.
16. Fridman, M.; Blakhov, V.; Yaron, S.; Baasov, T. A New Class of Branched Aminoglycosides: Pseudo-Pentasaccharide Derivatives of Neomycin B. Org. Lett. 2003, 5, 3575-3578.
17. Roestamadji, J.; Grapsas, I.; Mobashery, S. Mechanism-based Inactivation of Bacterial Aminoglycoside 3' Phosphotransferases. J. Am. Chem. Soc. 1995, 117, 80-84.
18. Hanessian, S.; Tremblay, M.; Swayze, E.E. Tobramycin Analouges with C-5 Aminoalkyl Ether Chains Intended to Mimic Rings III and IV of Paromomycin. Tetrahedron 2003, 59, 983-993.
19. Fridman, M.; Blakhov, V.; Lee, L.V.; Liang, F.S.; Wong, C.H.; Baasov, T. Dual Effect of Synthetic Aminoglycosides: Antibacterial Activity Against Bacillus Anthracis and Inhibition of Anthrax Lethal Factor. Angew. Chem. Int. Ed. 2005, 44, 447-452.
20. Ye, X.S.; Zhang, L.H. Aminoglycoside Mimetics as Small-molecule Drugs Targeting RNA. Curr. Med. Chem. 2002, 9, 929-939.
21. Arya, D.P. Design, Chemical Synthesis and Antibacterial Activity of Kanamycin and Neomycin Class Aminoglycoside Antibiotics. In Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery; Wiley: New Jersey, USA, 2007.
22. Kirk, S.R.; Luedtke, N.W.; Tor, Y. Neomycin-Acridine Conjugate: A Potent Inhibitor of Rev-RRE Binding. J. Am. Chem. Soc. 2000, 122, 980-981.
23. Kaiser, M.; Sainlos, M.; Lehn, J.; Bombard, S.; Teulade-Fichou, M. Aminoglycoside-quinacridine Conjugates: Towards Recognition of the P6.1 Element of Telomerase RNA. Chem. Bio. Chem. 2006, 7, 321-329.
24. Blount, K.F.; Tor, Y. A Tale of Two Targets: Differential RNA Selectivity of Nucleobase-Aminoglycoside Conjugates. Chem. Bio. Chem. 2006, 7, 1612-1621.
25. Charles, I.; Xi, H.; Arya, D.P. Sequence-specific Targeting of RNA with an Oligonuleotide-Neomycin Conjugate. Bioconjug. Chem. 2007, 18, 160-169.
26. Ahn, D.; Yu, J. Library Construction of Neomycin-dipeptide Heteroconjugates and Selection Against RRE RNA. Bioorg. Med. Chem. 2005, 13, 1177-1183.
27. Hyun, S.; Lee, K.H.; Yu, J. A Strategy for the Design of Selective RNA Binding Agents, Preparations and RRE RNA Binding Affinities of a Neomycin-peptide Nucleic Acid Heteroconjugate Library. Bioorg. Med. Chem. Lett. 2006, 16, 4757-4759.
28. Lee, J.; Kwon, M.; Lee, K.H.; Jeong, S.; Hyun, S.; Shin, K.J.; Yu, J. An Approach to Enhance Specificity Against RNA Targets Using Heteroconjugates of Aminoglycosides and Chloramphenicol (or Linezolid). J. Am. Chem. Soc. 2004, 126, 1956-1957.
29. Park, W.K.C.; Auer, M.; Jaksche, H.; Wong, C.H. Rapid Combinatorial Synthesis of Aminoglycoside Antibiotics Mimetics: Use of a Polyethylene glycol-linked Amine and Neamine Derived Aldehyde in Multicomponent Condensation as a Strategy for the Discovery of New Inhibitors of the HIV RNA Rev Response Element. J. Am. Chem. Soc.1996, 118, 10150-10155.
30. Greenberg, W.A.; Priestley, E.S.; Sears, P.S.; Alper, P.B.; Rosenbohn, C.; Hendrix, M.; Hung, S.C.; Wong, C.H. Design and Synthesis of New Aminoglycoside Antibiotics Containing Neamine as an Optimal Core: Correlation of Antibiotic Activity with in Vitro Inhibition of Translation. J. Am. Chem. Soc. 1999, 121, 6527-6541.
31. Nunns, C.L.; Spence, L.A.; Slater, M.J.; Berrisford, D.J. Synthesis of Neamine Libraries for RNA Recognition Using Solution Phase Chemistry. Tetrahedron Lett. 1999, 40, 9341-9345.
32. Ryu, D.H.; Tan, C.H.; Rando, R.R. Synthesis of (+), (-) Neamine and Their Positional Isomers as Potential Antibiotics. Bioorg. Med. Chem. Lett. 2003, 13, 901-903.
33. Minowa, N.; Akiyama, Y.; Hiraiwa, Y.; Maebashi, K.; Usui, T.; Ikeda, D. Synthesis and Antibacterial Activity of Novel Neamine Derivatives. Bioorg. Med. Chem. Lett. 2006, 16, 6351-6354.
34. Michael, K.; Wang, H.; Tor, Y. Enhanced RNA Binding of Dimerized Aminoglycosides. Bioorg. Med. Chem. 1999, 7, 1361-1371.
35. Wang, H.; Tor, Y. Dimeric Aminoglycosides: Design, Synthesis and RNA Binding. Bioorg. Med. Chem. Lett. 1997, 7, 1951-1956.
36. Sucheck, S.J.; Wong, A.L.; Koeller, K.M.; Boehr, D.D.; Draker, K.A.; Sears. P.; Wright, G.D.; Wong, C.H. Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-causing Enzymes. J. Am. Chem. Soc. 2000, 122, 5230-5231.
37. Tok, J.B.H.; Huffman, G.R. Enhanced Binding of Aminoglycoside Dimer to a "Dimerized" A-site rRNA Construct. Bioorg. Med. Chem. Lett. 2000, 10, 1593-1595.
38. Tok, J.B.H.; Dunn, L.J.; Des Jean, R.C. Binding of Dimeric Aminoglycosides to the HIV-1 Rev Response Element (RRE) RNA Construct. Bioorg. Med. Chem. Lett. 2001, 11, 1127-1131.
39. Tok, J.B.H.; Fenker J. Novel Synthesis and RNA-binding Properties of Aminoglycoside Dimers Conjugated via a Naphthalene diimide-based Intercalator. Bioorg. Med. Chem. Lett. 2001, 11, 2987-2991.
40. Leudtke, N.W.; Liu, Q.; Tor, Y. RNA-ligand Interactions: Affinity and Specificity of Aminoglycoside Dimers and Acridine Conjugates to the HIV-1 Rev Response Element. Biochemistry 2003, 42, 11391-11403.
41. Riguet, E.; Desire, J.; Boden, O.; Ludwig, V.; Gobel, M.; Bailly, C.; Decout, J.L. Neamine Dimers Targeting the HIV-1 TAR RNA. Bioorg. Med. Chem. Lett. 2005, 15, 4651-4655.
42. Liang, C.H.; Romero, A.; Rabuka, D.; Sgarbi, P.W.M.; Marby, K.A.; Duffield, J.; Yao, S.; Cheng, M.L.; Ichikawa, Y.; Sears, P.; Hu, C.; Hwang, S.B.; Shue, Y.K.; Sucheck, S.J. Structure-activity Releationship of Bivalent Aminoglycosides and Evaluation of Their Microbiological Activities. Bioorg. Med. Chem. Lett. 2005, 15, 2123-2128.
43. Chen, G.H.; Pan, P.; Chen, Y.; Meng, X.B.; Li, Z.J. Selective Deprotection of the Cbz Amine Protecting Group for the Facile Synthesis of Kanamycin A Dimers Linked at N-3'' Position. Tetrahedron 2009, 65, 5922-5927.
44. Busscher, G.F.; Rutjes, F.P.J.T.; van Delft, F.L. 2-Deoxystreptamine: Central Scaffold of Aminoglycoside Antibiotics. Chem. Rev. 2005, 205, 775-792.
45. Busscher, G.F.; Rutjes, F.P.J.T.; van Delft, F.L. Synthesis of a Protected Enantiomerically Pure 2-Deoxystreptamine Derivative from D-Allylglycine. Tetrahedron Lett. 2004, 69, 3629-3632.
46. Busscher, G.F.; Groothuys, S.; de Gelder, R.; Rutjes, F.P.J.T.; van Delft, F.L. Efficient Preparation of a 1,3-Diazidocyclitol as a Versatile 2-Deoxystreptamine Precursor. J. Org. Chem. 2004, 69, 4477-4481.
47. van den Broek, S.A.M.W.; Gruijters, B.W.T.; Rutjes, F.P.J.T.; van Delft, F.L.; Blaauw, R.H. A Short and Scalable Route to Orthogonally O-Protected 2-Deoxystreptamine. J. Org. Chem. 2007, 72, 3577-3580.
48. Aslam, M.W.; Busscher, G.F.; Weiner, D.P.; de Gelder, R.; Rutjes, F.P.J.T.; van Delft, F.L. Fully Orthogonally Protected 2-Deoxystreptamine from Kanamycin. J. Org. Chem. 2008, 73, 5131-5134.
49. Michael, K.; Wang, H.; Tor, Y. Enhanced RNA-Binding of Dimerized Aminoglycosides. Bioorg. Med. Chem. 1999, 7, 1361-1371.
50. Yu, L.; Oost, T.K.; Schkeryantz, J.M.; Yang, J.; Janowick, D.; Fesik, S.W. Discovery of Aminoglycoside Mimetics by NMR-based Screening of Escherichia Coli A-site RNA. J. Am. Chem. Soc. 2003, 125, 4444-4450.
51. Rodriguez, A.; Nomen, M.; Spur, B.W.; Godfroid, J.J. Selective Oxidation of Primary Silyl Ethers and its Application to the Synthesis of Natural Products. Tetrahedron Lett. 1999, 40, 5161-5164.
52. Luca, L.D.; Giacomelli, G.; Masala, S.; Porcheddu, A. Trichloroisocynauric/TEMPO Oxidation of Alcohols under Mild Conditions: A Close Investigation. J. Org. Chem. 2003, 68, 4999-5001.
53. More, J.D.; Finney, N.S. A Simple and Advantageous Protocol for the Oxidation of Alcohols with O-iodoxybenzoic Acid (IBX). Org. Lett. 2002, 4, 3001-3003.
54. Dess, D.B.; Martin, J.C. Readially Accessible12-1-5 Oxidant for the Conversion of Primary and Secondary Alcohols to Aldehydes and Ketones. J. Org. Chem. 1983, 48, 4155-4156.
55. Tornøe, C.W.; Christensen, C.; Meldal, M. Peptidotriazoles on Solid Phase: [1,2,3]-triazoles by Regiospecific Copper (I)-catalyzed 1,3-dipolar Cycloadditions of Terminal Alkynes to Azides. J. Org. Chem. 2002, 67, 3057-3064.
56. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B. A Stepwise Huisgen Cycloaddition Process: Copper (I)-catalyzed Regioselective Ligation of Azides and Terminal Alkynes. Angew. Chem. Int. Ed. 2002, 41, 2596-2599.
57. Jawalekar, A.M.; Cremers, N.M.J.G.O.; van der Marel, H.S.O.G.A.; Rutjes, F.P.J.T.; van Delft, F.L. Conjugation of Nucleosides and Oligonucleotides by [3+2] Cycloaddition. J. Org. Chem. 2008, 73, 287-290.
58. Wang, Y.; Killian, J.; Hamasaki, K.; Rando, R.R. RNA Molecules That Specifically and Stoichiometrically Bind Aminoglycoside Antibiotics with High Affinities. Biochemistry 1996, 35, 12338-12346.
59. Wang, Y.; Hamasaki, K.; Rando, R.R. Specificity of Aminoglycoside Binding to RNA Construct Derived from the 16S rRNA Decoding Region and the HIV-RRE Activator Region. Biochemistry 1997, 36, 768-779.
60. Wang, Y.; Hamasaki, K.; Rando, R.R. Specificity in the Binding of Aminoglycoside to HIV-RRE RNA. Biochemistry 1999, 38, 8548-8554.
61. Ryu, D.H.; Rando, R.R. Aminoglycoside Binding to Human and Bacterial A-site rRNA Decoding Region Construct. Bioorg. Med. Chem. 2001, 9, 2601-2608.
62. Ryu, D.H.; Litovchick, A.; Rando, R.R. Stereospecificity of Aminoglycoside-Ribosomal Interactions. Biochemistry 2002, 41, 10499-10509.
63. Luedtke, N.W.; Liu, Q.; Tor, Y. RNA-ligand Interactions: Affinity and Specificity of Aminoglycoside Dimers and Acridine Conjugates to the HIV-1 Rev Response Element. Biochemistry 2003, 42, 11391-11403.
64. Xiao, G.; Kumar, A.; Li, K.; Rigl, C.T.; Bajic, M.; Davis, T.M.; Boykin, D.W.; Wilson, W.D. Inhibition of the HIV-1 Rev-RRE Complex Formation by Unfused Aromatic Cations. Bioorg. Med. Chem. 2001, 9, 1097-1113.
65. Arya, D.P.; Coffee, R.L.; Xue, L. From Triplex to B-form Duplex Stabalization: Reversal of Target Selectivity by Aminoglycoside Dimers. Bioorg. Med. Chem. Lett. 2004, 14, 4643-4646.
66. Kaul, M.; Barbieri, C.M.; Pilch, D.S. Fluorescence-based Approach for Detecting and Characterizing Antibiotic-induced Conformational Changes in Ribosomal RNA: Comparing Aminoglycoside Binding to Prokaryotic and Eukaryotic Ribosomal RNA Sequences. J. Am. Chem. Soc. 2004, 126, 3447-3453.
67. Verhelst, S.H.; Michiels, P.J.; van der Marel, G.A.; van Boeckel, C.A.; van Boom, J.H. Surface Plasmon Resonance Evaluation of Various Aminoglycoside-RNA Hairpin Interactions Reveal Low Degree of Selectivity. Chem. Bio. Chem. 2004, 5, 937-942.
68. Agnelli, F.; Sucheck, S.J.; Marby, K.A.; Rabuka, D.; Yao, S.L.; Sears, P.S.; Liang, F.S.; Wong, C.H. Dimeric Aminoglycosides as Antibiotics. Angew. Chem. Int. Ed. 2004, 43, 1562-1566.
69. Swayze, E.E.; Jefferson, E.A.; Sannes-Lowery, K.A.; Blyn, L.B.; Risen, L.M.; Arakawa, S.; Osgood, S.A.; Hofstadler, S.A.; Griffey, R.H. SAR by MS: A Ligand Based Technique for Drug Lead Discovery Against Structured RNA Targets. J. Med. Chem. 2002, 45, 3816-3819.
70. Kaul, M.; Barbieri, C.M.; Pilch, D.S. Aminoglycoside-induced Reduction in Nucleotide Mobility at the Ribosomal RNA A-site as a Potentially Key Determinant of Antibacterial Activity. J. Am. Chem. Soc. 2006, 128, 1261-1271.
71. Strianese, M.; Zauner, G.; Tepper, A.W.J.W.; Bubacco, L.; Breukink, E.; Aartsma, T.J.; Canters, G.W.; Tabares, L.C. A Protein-based Oxygen Biosensor for High-throughput Mointoring of Cell Growth and Cell Viability. Anal. Biochem. 2009, 385, 242-248.
72. Zauner, G.; Strianes, M.; Bubacco, L.; Aartsma, T.J.; Tepper, A.W.J.W.; Canters, G.W. Tryptophan-to-dye Fluorescence Energy Transfer Applied to Oxygen Sensing by Using Type-3 Copper Proteins. Chem. Eur. J. 2007, 13, 7085-7090.